Journal
MOLECULAR METABOLISM
Volume 78, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.molmet.2023.101821
Keywords
Adiponectin; PPAR alpha; HNF4 alpha; beta cell
Categories
Ask authors/readers for more resources
The disease progression of metabolic syndrome is associated with the role of adiponectin in pancreatic islets, which maintains normal pancreatic function by regulating the expression of the transcription factors PPARa and HNF4a.
The disease progression of the metabolic syndrome is associated with prolonged hyperlipidemia and insulin resistance, eventually giving rise to impaired insulin secretion, often concomitant with hypoadiponectinemia. As an adipose tissue derived hormone, adiponectin is beneficial for insulin secretion and b cell health and differentiation. However, the down-stream pathway of adiponectin in the pancreatic islets has not been studied extensively. Here, along with the overall reduction of endocrine pancreatic function in islets from adiponectin KO mice, we examine PPARa and HNF4a as additional down-regulated transcription factors during a prolonged metabolic challenge. To elucidate the function of b cell specific PPARa and HNF4a expression, we developed doxycycline inducible pancreatic b cell-specific PPARa (b-PPARa) and HNF4a (b-HNF4a) overexpression mice. b-PPARa mice exhibited improved protection from lipotoxicity, but elevated b-oxidative damage in the islets, and also displayed lowered phospholipid levels and impaired glucose-stimulated insulin secretion. b-HNF4a mice showed a more severe phenotype when compared to b-PPARa mice, characterized by lower body weight, small islet mass and impaired insulin secretion. RNA-sequencing of the islets of these models highlights overlapping yet unique roles of b-PPARa and b-HNF4a. Given that b-HNF4a potently induces PPARa expression, we define a novel adiponectin-HNF4a-PPARa cascade. We further analyzed downstream genes consistently regulated by this axis. Among them, the islet amyloid polypeptide (IAPP) gene is an important target and accumulates in adiponectin KO mice. We propose a new mechanism of IAPP aggregation in type 2 diabetes through reduced adiponectin action.(c) 2023 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available